Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Caracteristics of the Patients Hospitalized With Unvonluntary Commitment Procedure, in the Context COVID-19 (HoCoPsy)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04417374
Recruitment Status : Completed
First Posted : June 4, 2020
Last Update Posted : July 29, 2020
Sponsor:
Information provided by (Responsible Party):
University Hospital, Montpellier

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:

The actual worldwide context (disease outbreak, confinements instaured in many countries) is a stressful factor for many people. It can have consequences on mental health : separation from loved ones, loss of freedom, uncertainty about infection status, boredom. Patients with mental disorders are especially vulnerable.

On march 17th, the french government ordonned a national confinement to slow the progression of the COVID-19 outbreak, for 15 days at first then renewed several times. This situation has led to a reorganization of care as requested on March 22nd, 2020 in the recommendations applicable to the organization of care in psychiatric services : priority to telephone contacts and teleconsultation by multiplying contacts and assessments.

By the time the reorganization of care became operational, the most vulnerable patients may have experienced a decompensation of their disease.

It is important to know if the COVID-19 outbreak combined with the confinement increased the number of unvoluntary commitment the month after the announce of the confinement.

This could help us understand which patients are more vulnerable is this context, and improve our organization (ambulatory and hospitalization care) if this situation occurs again.


Condition or disease Intervention/treatment
COVID 19 Disease Outbreak Mental Disorders Other: Description of groups caracteristics

Detailed Description:

The main objective is to notice if we can observe a increase in the number of unvonluntary commitment the month after the announce of the confinement in the psychiatric hospital La Colombière, CHU Montpellier, France.

Secondary objectives :

  • Describe the causes of unvonluntary commitment, and the principal psychiatric diagnostic of the patients
  • Assess the lengh of the hospitalization
  • Assess the number of patients hospitalized without psychiatric antecedent
  • Assess the number of treatment interruptions in the recent history before hospitalization
  • Asses the number of patients living alone
  • Asses the number of patients using drugs

It is expected to highlight :

  • An increase of the number of unvontuntary commitment
  • If one or several mental disorders were more at risk of requiring an unvonluntary commitment
  • An increased lengh of hospitalization
  • An increased number of unvonluntary commitment of patients without psychiatric antecedent
  • An increased number of treatment interruptions
  • A link between hospitalization and living alone
  • A link between hospitalization and using drugs

The medical file of all the patients unvonlutary commited from march 12th to April 09th 2020 are screened, and compared to the patients unvonlutary commited during the same period in 2019.

The caracteristics of interest are their age and sex, if the patient lives alone, the matter of hospitalization, its lengh, their primary psychiatric diagnostic, the use of toxics at the moment of the hospitalization and if this psychiatric decompensation happens in a context of treatment interruption.

Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational
Actual Enrollment : 94 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Caracteristics of the Patients Hospitalized With Unvonluntary Commitment Procedure, in Pandemic and Confinement Context
Actual Study Start Date : May 1, 2020
Actual Primary Completion Date : May 30, 2020
Actual Study Completion Date : June 30, 2020
Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Group/Cohort Intervention/treatment
Unvonluntary commitment from March 12th to April 09th 2019
Patients hospitalized with unvonluntary commitment procedure from March 12th to April 09th 2019
 Other: Description of groups caracteristics
Comparison of the two groups on all the following criterias : age, sex, if the patient lives alone, the matter of hospitalization, its lengh, their primary psychiatric diagnostic, the use of toxics at the moment of the hospitalization and if this psychiatric decompensation happens in a context of treatment interruption.
Unvonluntary commitment from March 12th to April 09th 2020
Patients hospitalized with unvonluntary commitment procedure from March 12th to April 09th 2020
 Other: Description of groups caracteristics
Comparison of the two groups on all the following criterias : age, sex, if the patient lives alone, the matter of hospitalization, its lengh, their primary psychiatric diagnostic, the use of toxics at the moment of the hospitalization and if this psychiatric decompensation happens in a context of treatment interruption.


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Number of hospitalized patients [ Time Frame: 1 months ]
    Number of hospitalized patients From March 12th to April 09th


Secondary Outcome Measures :
  1. Cause of hospitalization [ Time Frame: 1 months ]
    Primary psychiatric diagnostic From March 12th to April 09th


Other Outcome Measures:
  1. Lengh of hospitalization [ Time Frame: 1 months ]
    Patients without psychiatric antecedent (number) From March 12th to April 09th

  2. Treatment interruption [ Time Frame: 1 months ]
    Presence of absence of history of treatment interruption leading to the hospitalization From March 12th to April 09th

  3. Number of hospitalized patients living alone [ Time Frame: 1 months ]
    Number of hospitalized patients living alone (opposed to those living with family) From March 12th to April 09th

  4. Use of drugs [ Time Frame: 1 months ]
    Number of patients using drugs From March 12th to April 09th


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Adults having been aditted to the psychiatric hospital La Colombière, CHU Montpellier, France, with unvonluntary commitment procedure from march 12th to April 09th (2019 and 2020)
Criteria

Inclusion criteria:

- Unvonluntary commitment in psychiatric hospital La Colombière, CHU Montpellier, from march 12th to april 19th (2019 and 2020).

Exclusion criteria:

- refusal to participate

Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04417374


Locations
Layout table for location information
France
University hospital
Montpellier, France, 34295
Sponsors and Collaborators
University Hospital, Montpellier
Investigators
Layout table for investigator information
Principal Investigator: Emilie Olie, MD PhD University Hospital, Montpellier
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: University Hospital, Montpellier
ClinicalTrials.gov Identifier: NCT04417374    
Other Study ID Numbers: RECHMPL20_0320
First Posted: June 4, 2020    Key Record Dates
Last Update Posted: July 29, 2020
Last Verified: July 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided
Plan Description: NC

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by University Hospital, Montpellier:
Confinement
Disease outbreak
Unvonluntary commitment
Additional relevant MeSH terms:
Layout table for MeSH terms
Mental Disorders